A D Marais1. 1. Division of Chemical Pathology, Pathology Department, University of Cape Town Health Science Faculty, Anzio Rd, Observatory, Cape Town, 7925, South Africa. david.marais@uct.ac.za.
Abstract
PURPOSE OF REVIEW: The functions, genetic variations and impact of apolipoprotein E on lipoprotein metabolism in general are placed in the context of clinical practice dealing with moderate dyslipidaemia as well as dysbetalipoproteinemia, a highly atherogenic disorder and lipoprotein glomerulopathy. RECENT FINDINGS: Additional variants of apolipoprotein E and participation of apolipoprotein E in inflammation are of interest. The mostly favourable effects of apolipoprotein E2 as well as the atherogenic nature of apolipoproteinE4, which has an association with cognitive impairment, are confirmed. The contribution of remnant lipoproteins of triglyceride-rich lipoproteins, of which dysbetalipoproteinemia represents an extreme, is explored in atherosclerosis. Mimetic peptides may present new therapeutic approaches. Apolipoprotein E is an important determinant of the lipid profile and cardiovascular health in the population at large and can precipitate dysbetalipoproteinemia and glomerulopathy. Awareness of apolipoprotein E polymorphisms should improve medical care.
PURPOSE OF REVIEW: The functions, genetic variations and impact of apolipoprotein E on lipoprotein metabolism in general are placed in the context of clinical practice dealing with moderate dyslipidaemia as well as dysbetalipoproteinemia, a highly atherogenic disorder and lipoprotein glomerulopathy. RECENT FINDINGS: Additional variants of apolipoprotein E and participation of apolipoprotein E in inflammation are of interest. The mostly favourable effects of apolipoprotein E2 as well as the atherogenic nature of apolipoproteinE4, which has an association with cognitive impairment, are confirmed. The contribution of remnant lipoproteins of triglyceride-rich lipoproteins, of which dysbetalipoproteinemia represents an extreme, is explored in atherosclerosis. Mimetic peptides may present new therapeutic approaches. Apolipoprotein E is an important determinant of the lipid profile and cardiovascular health in the population at large and can precipitate dysbetalipoproteinemia and glomerulopathy. Awareness of apolipoprotein E polymorphisms should improve medical care.
Authors: Palaniappan S Chetty; Leland Mayne; Sissel Lund-Katz; S Walter Englander; Michael C Phillips Journal: Proc Natl Acad Sci U S A Date: 2017-01-17 Impact factor: 11.205
Authors: Constantin N Takacs; Ursula Andreo; Rachel L Belote; Joan Pulupa; Margaret A Scull; Caroline E Gleason; Charles M Rice; Sanford M Simon Journal: Traffic Date: 2017-01-31 Impact factor: 6.215
Authors: Brian J Bennett; Richard C Davis; Mete Civelek; Luz Orozco; Judy Wu; Hannah Qi; Calvin Pan; René R Sevag Packard; Eleazar Eskin; Mujing Yan; Todd Kirchgessner; Zeneng Wang; Xinmin Li; Jill C Gregory; Stanley L Hazen; Peter S Gargalovic; Aldons J Lusis Journal: PLoS Genet Date: 2015-12-22 Impact factor: 5.917
Authors: Jeong Shim; Christian Bo Poulsen; Mette K Hagensen; Torben Larsen; Peter M H Heegaard; Christina Christoffersen; Lars Bolund; Mette Schmidt; Ying Liu; Juan Li; Rong Li; Henrik Callesen; Jacob F Bentzon; Charlotte B Sørensen Journal: JACC Basic Transl Sci Date: 2017-10-30
Authors: Leandro de Jesus Benevides; Daniel Santana de Carvalho; Roberto Fernandes Silva Andrade; Gilberto Cafezeiro Bomfim; Flora Maria de Campos Fernandes Journal: Genet Mol Biol Date: 2016-07-14 Impact factor: 1.771